ClinicalTrials.Veeva

Menu

Home-based Intermittent Pneumatic Compression Therapy for Gynecologic Cancer

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Gynecologic Cancer
Lymphedema of Leg

Treatments

Device: home-based intermittent pneumatic compression (IPC) device

Study type

Interventional

Funder types

Other

Identifiers

NCT05193357
homepump_study

Details and patient eligibility

About

Investigators conducted a prospective study of cancer patients to investigate the efficacy, quality of life, satisfaction, and safety of a home-based intermittent pneumatic compression (IPC) device during the maintenance phase of lower extremity lymphedema. This device has a unique mode designed to mimic the manual lymphatic drainage (MLD) technique and thereby gently facilitate lymphatic draining of proximal extremities.

Enrollment

30 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stage 3 chronic unilateral secondary leg lymphedema
  • aged 20-70 years
  • underwent 1-2 cycle of treatment of decongestive phase with current inter-limb volume difference of more than 10%
  • stable limb-volume change (within 10%) during the preceding 3 months
  • capacity for self-maintenance care for lymphedema (multilayer limb bandaging, compression garments, and MLD)

Exclusion criteria

  • bilateral leg lymphedema
  • current cancer metastasis
  • ongoing chemotherapy or radiation therapy
  • acute inflammation
  • venous thrombosis, or chronic venous insufficiency
  • systemic etiologies of edema
  • congestive heart failure
  • patients taking medication that influenced body fluid or electrolytes

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

home-based IPC device
Experimental group
Description:
Participants used a device produced by Maxstar Corp. (Gimpo, South Korea), which specializes in pneumatic compression appliance manufacture. The IPC device (UAM-9306NB) was cleared by National Institute of Medical Device Safety Information (NIDS) of Korea (approval number: 18-4745). This device consists of a six-chamber pneumatic sleeve and a gradient-sequential pneumatic pump.
Treatment:
Device: home-based intermittent pneumatic compression (IPC) device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems